Clinical trial · Observational
A Predictive Nomogram for Trismus After Radiotherapy for Head and Neck Cancer
NCT05777668CI-TRIAL-00064877completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Background: The aim of this study is to develop a prediction model for radiation-induced trismus (maximal interincisal distance equal to or less than 35 mm) based on a multivariable analysis of dosimetric and clinical factors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Trismus | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Volumetric modulated radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Head and neck cancer patients undergoing radiotherapy
- interventionNames
- Radiation: Volumetric modulated radiotherapy
Primary outcomes (1)
- measure
- Trismus
- timeFrame
- 6 months
- description
- maximal interincisal distance equal to or less than 35 mm
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * HNC * treatment definitive or postoperative external beam radiotherapy, either alone or in -combination with chemotherapy or cetuximab at least 6 months follow-up Exclusion Criteria: * primary tumor out-side the head and neck region, intracranially, or if it originated from the nasal vestibule * patient death during RT or within the first 6 months after the start of RT, no outcome data available
References
Publications (0)
Data not yet available
No reference posted for this study.